FIELD: biochemistry, proteins, cytokines. SUBSTANCE: invention relates to polypeptides including the following sequence: Thr-X4-Lys-X5-Arg-X6 where X4 and X5 are taken independently among group comprising of Met, Ile, Leu and Val and X6 is taken among group comprising of Asn, Asp, Gln and Glu. Compounds show IL-10-like activity and can be used as agonists or antagonists of IL-10 (interleukin-10). Invention describes also pharmaceutical composition comprising indicated polypeptide and method of its preparing. EFFECT: improved method of preparing, valuable properties. 23 cl, 14 dwg, 5 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
POLYPEPTIDE WITH IL-10-SIMILAR PROPERTY (VARIANT), POLYPEPTIDE CONJUGATE, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF IMMUNE RESPONSE IN MAMMAL | 1995 |
|
RU2218348C2 |
ANTIBODIES AND POLYPEPTIDES AGAINST CD127 | 2017 |
|
RU2769352C2 |
RECOMBINANT CHIMERIC PROTEIN ANTH1, NUCLEIC ACID ENCODING ITS AND THEIR USING | 2003 |
|
RU2322455C2 |
ANTIBODIES DIRECTED TO CD127 | 2015 |
|
RU2734076C2 |
HUMANIZED ANTI-IL17A ANTIBODY AND ITS APPLICATION | 2020 |
|
RU2804963C2 |
METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | 2017 |
|
RU2772434C2 |
ANTIBODY AGAINST INTERFERON-ALPHA/BETA-CONNECTING PROTEIN II (IFNAB-BPII) | 1995 |
|
RU2362781C2 |
ANTIBODIES AGAINST HUMAN VSIG4 AND APPLICATION THEREOF | 2019 |
|
RU2776638C1 |
MODIFIED HEMATOPOIETIC STEM CELLS/PROGENITOR CELLS AND NON-T EFFECTOR CELLS, AND USE THEREOF | 2014 |
|
RU2733652C2 |
ANTIBODY AGAINST INTERFERON-α/β-BINDING PROTEIN I (IFNAB-BPI) | 1995 |
|
RU2363705C2 |
Authors
Dates
2002-12-10—Published
1997-01-16—Filed